Other contributing factors may include immunosuppressive cytokines (e.g., interleukin-10, TGF-β), metabolic stress within the tumor microenvironment, hormonal influences, and insufficient CD4+ T-cell help during early priming. The gene discussed is TGFB1; the disease is neoplasm.